DS

Dhirendra Saini

Active Director Director DIN 07438645
DIN 07438645 First appointment Feb 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value •••• Premium profile

About Dhirendra Saini

Data last updated:

Dhirendra Saini is a Director at Macleaypharmaceuticals Private Limited (since 2016). The company operates in Trading. Macleaypharmaceuticals Private Limited reported revenue of ₹4.6 Lakh (FY 2025).

DIN 07438645
Primary Designation Director
Industry Trading
First Appointment 24 Feb 2016
Oldest Company Age 10 yrs
Largest company Macleaypharmaceuticals Private Limited · ₹4.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Feb 20162016₹4.6 Lakh (FY 2025)Active

Board colleagues of Dhirendra Saini

Directorship timeline

Open interactive timeline →
Macleaypharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dhirendra Saini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhirendra Saini

Dhirendra Saini currently holds 1 directorship: Macleaypharmaceuticals Private Limited (Director, since 24 Feb 2016, revenue ₹4.6 Lakh (FY 2025)).

Dhirendra Saini was first appointed on 24 Feb 2016 as Director at Macleaypharmaceuticals Private Limited.

The current boards of Dhirendra Saini's companies include Mohammad Tanzeem Khan (Macleaypharmaceuticals Private Limited), Yasmeen Naseem (Macleaypharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available